Cargando…

Need for expanded Candida Score for empiric antifungal use in medically critically ill patients?

Detalles Bibliográficos
Autores principales:	Laine, Melanie E., Flannery, Alexander H., Moody, Breanna, Thompson Bastin, Melissa L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609394/ https://www.ncbi.nlm.nih.gov/pubmed/31272491 http://dx.doi.org/10.1186/s13054-019-2525-3

Ejemplares similares

Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU
por: Bruyère, Rémi, et al.
Publicado: (2014)

Factors predicting prolonged empirical antifungal treatment in critically ill patients
por: Zein, Mohamed, et al.
Publicado: (2014)

Empirical antifungal treatment in the critically ill patients: how does it impact on the outcome?
por: Bruyère, R, et al.
Publicado: (2012)

Application of a new Candida score for early antifungal treatment in an adult medical – surgical critical care unit
por: Santos, M, et al.
Publicado: (2007)

Antifungal prophylaxis in critically ill patients
por: Silvestri, Luciano, et al.
Publicado: (2008)

Antifungal stewardship in critically ill patients
por: De Pascale, Gennaro, et al.
Publicado: (2023)

An Observational Study on Early Empiric versus Culture-Directed Antifungal Therapy in Critically Ill with Intra-Abdominal Sepsis
por: Lee, Winnie, et al.
Publicado: (2014)

Usefulness of quantitative analysis of beta-D-glucan in empirical therapy for systematic Candida infection in critically ill patients
por: Kano, I, et al.
Publicado: (2005)

2113. Evaluation of Empiric Antifungal Therapy in Critically Ill Patients with Liver Disease, Sepsis, and No Evidence of Active Fungal Infection
por: Britt, Rachel S, et al.
Publicado: (2019)

Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022)

Evaluation of the updated “Candida score” with Sepsis 3.0 criteria in critically ill patients
por: Li, Dongkai, et al.
Publicado: (2020)

De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety
por: Jaffal, Karim, et al.
Publicado: (2018)

Candida endophthalmitis: A critical diagnosis in the critically ill
por: Au, L, et al.
Publicado: (2007)

Evaluation of "Candida score" in critically ill patients: a prospective, multicenter, observational, cohort study
por: Leroy, Guillaume, et al.
Publicado: (2011)

Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy
por: Kunka, Megan E., et al.
Publicado: (2015)

Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebocontrolled pilot trial (CANTREAT study)
por: Albert, M, et al.
Publicado: (2014)

Evaluation of Candida colonization index, molecular identification, and antifungal susceptibility pattern of Candida species isolated from critically ill pediatric patients: A single-center study in Iran
por: Davari, Amirhossein, et al.
Publicado: (2022)

806. Candida Gut Colonization in Critically Ill Patients
por: Adelman, Max W, et al.
Publicado: (2023)

Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation
por: Lyster, Haifa, et al.
Publicado: (2023)

Candida Species Biofilms’ Antifungal Resistance
por: Silva, Sónia, et al.
Publicado: (2017)

Impact of protocolized diuresis for de-resuscitation in the intensive care unit
por: Bissell, Brittany D., et al.
Publicado: (2020)

Candida glabrata candidemia: An emerging threat in critically ill patients
por: Gupta, Ashish, et al.
Publicado: (2015)

Severe Candida infections in critically ill patients with COVID-19
por: Koulenti, Despoina, et al.
Publicado: (2023)

Posaconazole exposure in critically ill ICU patients: a need for action
por: König, Christina, et al.
Publicado: (2023)

Risk factors for Candida colonization/infection in non-neutropenic medical critically ill patients
por: Nolla, J, et al.
Publicado: (2001)

Incidence and Antifungal Susceptibility of Candida Albicans Infections
por: UNGUREANU, A., et al.
Publicado: (2016)

Antifungal Resistance in Candida auris: Molecular Determinants
por: Frías-De-León, María Guadalupe, et al.
Publicado: (2020)

Identification and Elimination of Antifungal Tolerance in Candida auris
por: Rasouli Koohi, Samira, et al.
Publicado: (2023)

Sphingosine as a New Antifungal Agent against Candida and Aspergillus spp.
por: Hashemi Arani, Fahimeh, et al.
Publicado: (2022)

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)

Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients
por: Maseda, Emilio, et al.
Publicado: (2018)

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
por: Ishida, Kelly, et al.
Publicado: (2011)

In vitro antifungal potency of the moronecidin-like peptide against Candida albicans, Candida glabrata, and Candida tropicalis
por: Amirrajab, Nasrin, et al.
Publicado: (2023)

Bulletin comment: Ever-expanding empires(†)
Publicado: (2015)

Comments on “Candida glabrata candidemia; an emerging threat in critically ill patients”
por: Ahmed, Armin, et al.
Publicado: (2015)

Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal
por: Costa-de-Oliveira, Sofia, et al.
Publicado: (2020)

Synergistic Antifungal Activity of Chito-Oligosaccharides and Commercial Antifungals on Biofilms of Clinical Candida Isolates
por: Ganan, Monica, et al.
Publicado: (2021)

Antifungal Activity of Select Essential Oils against Candida auris and Their Interactions with Antifungal Drugs
por: Parker, Ryan A., et al.
Publicado: (2022)

Infection of Tissue Expander With Candida Parapsilosis
por: Lavi, Eran, et al.
Publicado: (2012)

In Vitro Antifungal Activity of Three Synthetic Peptides against Candida auris and Other Candida Species of Medical Importance
por: Torres, Richar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0mk527r1tccil6ddp89u073eo0